Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in Mexico

OBJECTIVE: To assess the safety and immune responses induced by a 13-valent pneumococcal conjugate vaccine (PCV13) after immunization of infants in Mexico. METHODS: PCV13 was given with other routine childhood vaccinations to 225 infants in Mexico at ages 2, 4, 6, and 12 months. RESULTS: The proport...

Full description

Bibliographic Details
Main Authors: Maricruz Gutiérrez Brito, Allison Thompson, Douglas Girgenti, Peter C. Giardina, Denise A. Sarkozy, William C. Gruber, Emilio A. Emini, Daniel A. Scott
Format: Article
Language:English
Published: Pan American Health Organization 2013-06-01
Series:Revista Panamericana de Salud Pública
Subjects:
Vacunas neumocócicas
seguridad
neumonía
México
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013000600005&lng=en&tlng=en

Internet

http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013000600005&lng=en&tlng=en

Similar Items